ABSTRACT
Cellular migration is a ubiquitous feature of development that brings brain cells into appropriate spatial relationships. Cortical thinning has been reported in post-mortem brain samples of patients with bipolar disorder (BD). It could be that defective cellular migration during brain development is one of the contributing mechanisms in BD pathogenesis, leading to abnormalities reported at post-mortem, and during brain imaging. To probe the role of cellular migration in BD, we conducted time-lapse analysis of migration of neural precursor cells (NPCs) previously generated in our laboratory. Two NPC lines (B1 and B2) and one control line (C1) were used for the cell migration experiments. Time-lapse images were recorded every 15 min, for 15 hours, and analysed for speed and direction of cellular migration. Abnormalities in cellular migration was a common feature observed in both patient-derived NPCs. Consequently, we investigated underlying mechanistic irregularities in B1 and B2 lines that may contribute to the observed phenotype. To this end, transcriptional changes were compared between the patient-derived cells with the control line. Additionally, we examined exonic variations in genes related to cellular migration or motility. Our analysis showed downregulation of multiple genes that are all part of the EGF/ERBB signaling pathway. Collective dysregulation may be producing the defective cellular phenotype. These cellular migration abnormalities may be linked to structural changes in the brain reported in bipolar disorder.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by a grant from the Department of Biotechnology (COE), India funded grants- Targeted generation and interrogation of cellular models and networks in neuro-psychiatric disorders using candidate genes (BT/01/CEIB/11/VI/11/2012) and Accelerating program for discovery in brain disorders using stem cells (BT/PR17316/MED/31/326/2015) (ADBS); the Department of Science and Technology, India funded grants- Imaging-genomics approach to identify molecular markers of Lithium response in Bipolar disorder through the DST-INSPIRE Faculty Fellowship awarded to Dr. Biju Viswanath (Project number 00671, Code: IFA-12-LSBM-44) and SCIENCE& ENGINEERING RESEARCH BOARD (SERB) project Dissecting the biology of lithium response in human induced pluripotent stem cell derived neurons from patients with bipolar affective disorder (FILE NO. ECR/2016/002076).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study protocol has been approved by the ethics committee of the National Institute of Mental Health and Neurosciences, Bengaluru, India (No. NIMHANS/DO/96TH lEC/2015). Clinical protocol for this study conforms to the ethical norms and standards in the Declaration of Helsinki. Committee decision: protocol approved Committee members: 1. Dr. AK Kurpad, Professor of Physiology, NIMHANS; Chair, Ethics committee 2. Mr. AR Patil, Professor, National Law School of India; legal expert on the Ethics committee 3. Dr. Dennis Xavier, Prof. & Head, Dept of Pharmacology, St. John's Medical College 4. Dr. Rajaram Subbian, social scientist on the ethics committee 5. Dr. Pratima Murthy, Dept. of Psychiatry, NIMHANS 6. Dr. Pramod Pal, Dept. of Neurology, NIMHANS 7. Dr. M. Jayaram, Dept of Speech Pathology & Audiology 8. Dr. V. Ravi, Dept. of Neurovirology, NIMHANS 9. Dr. B.N. Gangadhar, Dept. of Psychiatry, NIMHANS
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Available upon request
